CTOs on the Move

MFCP - Motion & Flow Control Products, Inc.

www.mfcp.com

 
Motion and Flow Control Products Inc. has been building its reputation as service-focused industrial fluid power, motion, and process control products distributor since 1960. Today, our customers also come to us for hydraulic system engineering, design, and manufacturing; hydraulic component repairs; hydraulic system service and troubleshooting; hydraulic and industrial filtration solutions; remote system condition monitoring and implementation, and more. In short, if your system has anything to do with hydraulics, pneumatics, or process control, we have an expert on staff who can help you with design, troubleshooting, and maintenance. We support our customers through 44 locations in Alaska, Arizona, California, ...
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.mfcp.com
  • W Toller Ave
    Littleton, CO USA
  • Phone: 303.762.8012

Executives

Name Title Contact Details

Similar Companies

Omega Marketing Group

Omega Marketing Group, Inc is a Chicago, IL-based company in the Business Services sector.

Brittany Dyeing and Printing Corporation

Brittany Dyeing and Printing Corporation is a New Bedford, MA-based company in the Business Services sector.

TIXiMED

TIXiMED, Inc. is focused on developing and commercializing TXNIP inhibiting medication as a first-of-its-kind oral therapeutic for Type 1 and Type 2 diabetes. TIXiMED is the exclusive license holder for the patent (composition of matter and method of use) surrounding TIX100, a novel small molecule that normalizes pancreatic beta cell TXNIP, a detrimental protein elevated in Type 1 and Type 2 diabetes. Increased TXNIP causes pancreatic islet dysfunction and death of insulin-producing beta cells and thereby contributes to the development and progression of diabetes. Diabetes affects more than half a billion people worldwide. Those affected by Type 1 diabetes are dependent on multiple daily insulin injections or continuous insulin infusions to stay alive and manage their blood sugar. Oral anti-diabetic drugs are only approved for Type 2 diabetes, but can be associated with multiple side effects, underlining the need for novel and better oral diabetes medications for Type 1 and Type 2 diabetes. TXNIP inhibition has recently been demonstrated to be an effective and safe therapeutic approach in adults and children with recent onset Type 1 diabetes and TIX100 shows beneficial, anti-diabetic effects in 4 different mouse models. Advantages of TIX100 include oral availability, no associated hypoglycemia or weight gain, potent inhibition of detrimental TXNIP in human islets, and a favorable pharmacokinetic and safety profile. In addition, TIX100 inhibits excessive glucagon secretion and hepatic glucose production and protects against fatty liver. Thus, TIX100 holds promise for durable, weight-neutral improvement in glycemic control in Type 1 and Type 2 diabetes by targeting common underlying pathology and promoting patients own islet cell health.

Livonia Chamber

The Livonia Chamber of Commerce provides information, marketing, networking, and advocacy programs that promote the Chamber’s 1,000+ members and the entire Livonia community. The Livonia Chamber’s membership consists of large and small businesses and a...

Digital Outpost

Digital Outpost is a Carlsbad, CA-based company in the Business Services sector.